proteins, which constitute a family of three homologs of 8 Present address:
). Control (92 Ϯ 7 pC, n ϭ 10, m/m; 96 Ϯ 4 fC, n ϭ 12, wild-type) of spontaneous responses were not different between experiments showed that inactive ␣-PE variants, which do not bind to C 1 domains, had no effect on evoked m/m and wild-type neurons. In a separate set of experiments, we found that evoked EPSC amplitudes from EPSCs in both wild-type (n ϭ 9) and m/m neurons (n ϭ 12). Because numerous reports showed ␤-PE-depenMunc13-2-deficient cells that express Munc13-1 as the only Munc13 isoform (1.32 Ϯ 0.27 nA, n ϭ 17) were dent increases in mEPSC frequency, we examined the effect of 1 M PDBU on mEPSC frequency in control indistinguishable from responses measured in Munc13-1/ Munc13-2 double-deficient neurons overexpressing and m/m neurons. We found that in wild-type neurons, the mEPSC frequency increased to 239% Ϯ 34% (n ϭ neurons using the Semliki-Forest-Virus system and Figure 3C ). In contrast, m/m neurons showed a strongly reduced sensitivity toward ␤-PE with application of 1 tested their sensitivity to ␤-PEs. Similar to wild-type lyzed by autoradiography. In parallel, aliquots of the same samples were analyzed by Western blotting for Munc13-1 and densitometric analysis. We found that Following washout of PDBU, application of BIS I (3 M)
Munc13-1 was weakly phosphorylated in a constitutive, led to a partial and irreversible rundown of evoked EPSC ␤-PE-independent manner in all genotypes tested (Figamplitudes. The degree of this rundown was dependent ure 5E). However, in wild-type and m/m brains, a ␤-PEon the stimulation frequency (35% at 0.2 Hz, n ϭ 7, and dependent phosphorylation of Munc13-1 was not ob-15% at 0.033 Hz, n ϭ 7, over a 4 min application period; served. The ratio between immunoprecipitated and Figures 4A and 4B) . However, the resulting reduced phosphorylated Munc13-1 was very similar between all evoked EPSC responses were still potentiated by appligenotypes and treatment groups, indicating that cation of 1 M PDBU, and the degree of this potentiation Munc13-1 is not a PKC target ( Figure 5E ). was similar to the one observed with PDBU alone (Figures 4A and 4C) . This effect compromises the use of this drug as a view is based on three key findings First, mutant m/m pharmacological tool. Moreover, an alternative PKC inneurons exhibit a dramatic reduction in ␤-PE sensitivity hibitor, GÖ 6983, had no effect on the ␤-PE-induced of transmitter release (Figures 3C and 3D) . This reducincrease in transmitter secretion studied here. Thus, tion is complete when the contribution of wild-type published pharmacological data on the role of PKCs in Munc13-2 is abolished (Figures 3E and 3F) 
